Cargando…
Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA express...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188446/ https://www.ncbi.nlm.nih.gov/pubmed/27929393 http://dx.doi.org/10.3390/nu8120791 |
_version_ | 1782487035875950592 |
---|---|
author | Lim, Eunjin Lim, Ji Ye Kim, Eunju Kim, Yoo-Sun Shin, Jae-Ho Seok, Pu Reum Jung, Sangwon Yoo, Sang-Ho Kim, Yuri |
author_facet | Lim, Eunjin Lim, Ji Ye Kim, Eunju Kim, Yoo-Sun Shin, Jae-Ho Seok, Pu Reum Jung, Sangwon Yoo, Sang-Ho Kim, Yuri |
author_sort | Lim, Eunjin |
collection | PubMed |
description | Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA expression in db/db mice. For six weeks, C57BL/KsJ-db/db mice received 5% XB as part of the total sucrose content of their diet. XB supplementation improved glucose tolerance with reduced levels of OGTT AUC, fasting blood glucose, HbA1c, insulin, and HOMA-IR. Furthermore, XB supplementation decreased the levels of total triglycerides, total cholesterol, and LDL-C. The expression levels of miR-122a and miR-33a were higher and lower in the XB group, respectively. In the liver, expressions of the lipogenic genes, including, fatty acid synthase (FAS), peroxisome proliferator activated receptor γ (PPARγ), sterol regulatory element-binding protein-1C (SREBP-1C), sterol regulatory element-binding protein-2 (SREBP-2), acetyl-CoA carboxylase (ACC), HMG-CoA reductase (HMGCR), ATP-binding cassette transporter G5/G8 (ABCG5/8), cholesterol 7 alpha-hydroxylase (CYP7A1), and sterol 12-alpha-hydroxylase (CYP8B1), as well as oxidative stress markers, including superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), glutathione peroxidase (GPX), and catalase, were also regulated by XB supplementation. XB supplementation inhibited the mRNA expressions levels of the pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1, as well as phosphorylation of c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), p38 mitogen-activated protein kinases (MAPK), and extracellular signal-regulated kinases 1/2 (ERK1/2). These data demonstrate that XB exhibits anti-diabetic, hypolipogenic, and anti-inflammatory effects via regulation of the miR-122a/33a axis in db/db mice. |
format | Online Article Text |
id | pubmed-5188446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-51884462017-01-03 Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice Lim, Eunjin Lim, Ji Ye Kim, Eunju Kim, Yoo-Sun Shin, Jae-Ho Seok, Pu Reum Jung, Sangwon Yoo, Sang-Ho Kim, Yuri Nutrients Article Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA expression in db/db mice. For six weeks, C57BL/KsJ-db/db mice received 5% XB as part of the total sucrose content of their diet. XB supplementation improved glucose tolerance with reduced levels of OGTT AUC, fasting blood glucose, HbA1c, insulin, and HOMA-IR. Furthermore, XB supplementation decreased the levels of total triglycerides, total cholesterol, and LDL-C. The expression levels of miR-122a and miR-33a were higher and lower in the XB group, respectively. In the liver, expressions of the lipogenic genes, including, fatty acid synthase (FAS), peroxisome proliferator activated receptor γ (PPARγ), sterol regulatory element-binding protein-1C (SREBP-1C), sterol regulatory element-binding protein-2 (SREBP-2), acetyl-CoA carboxylase (ACC), HMG-CoA reductase (HMGCR), ATP-binding cassette transporter G5/G8 (ABCG5/8), cholesterol 7 alpha-hydroxylase (CYP7A1), and sterol 12-alpha-hydroxylase (CYP8B1), as well as oxidative stress markers, including superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), glutathione peroxidase (GPX), and catalase, were also regulated by XB supplementation. XB supplementation inhibited the mRNA expressions levels of the pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1, as well as phosphorylation of c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), p38 mitogen-activated protein kinases (MAPK), and extracellular signal-regulated kinases 1/2 (ERK1/2). These data demonstrate that XB exhibits anti-diabetic, hypolipogenic, and anti-inflammatory effects via regulation of the miR-122a/33a axis in db/db mice. MDPI 2016-12-05 /pmc/articles/PMC5188446/ /pubmed/27929393 http://dx.doi.org/10.3390/nu8120791 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lim, Eunjin Lim, Ji Ye Kim, Eunju Kim, Yoo-Sun Shin, Jae-Ho Seok, Pu Reum Jung, Sangwon Yoo, Sang-Ho Kim, Yuri Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title | Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title_full | Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title_fullStr | Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title_full_unstemmed | Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title_short | Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice |
title_sort | xylobiose, an alternative sweetener, ameliorates diabetes-related metabolic changes by regulating hepatic lipogenesis and mir-122a/33a in db/db mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188446/ https://www.ncbi.nlm.nih.gov/pubmed/27929393 http://dx.doi.org/10.3390/nu8120791 |
work_keys_str_mv | AT limeunjin xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT limjiye xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT kimeunju xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT kimyoosun xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT shinjaeho xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT seokpureum xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT jungsangwon xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT yoosangho xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice AT kimyuri xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice |